nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis
|
Hu, Guoming |
|
|
25 |
10 |
p. 1747-1756 |
artikel |
2 |
Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience
|
Zhou, Rui |
|
|
25 |
10 |
p. 1822-1829 |
artikel |
3 |
Comparison of 2- and 4-week S-1 administration as adjuvant chemotherapy for advanced gastric cancer
|
Ogawa, Koichi |
|
|
25 |
10 |
p. 1807-1813 |
artikel |
4 |
Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study
|
Gökyer, Ali |
|
|
25 |
10 |
p. 1757-1762 |
artikel |
5 |
Correction to: Recent advances of the regulation roles of MicroRNA in glioblastoma
|
Yan, Chengrui |
|
|
25 |
10 |
p. 1879 |
artikel |
6 |
Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection
|
Onuma, Toshimichi |
|
|
25 |
10 |
p. 1854-1860 |
artikel |
7 |
Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes
|
Shoji, Sunao |
|
|
25 |
10 |
p. 1844-1853 |
artikel |
8 |
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study
|
Nakano, Shintaro |
|
|
25 |
10 |
p. 1800-1806 |
artikel |
9 |
Incidence and risk factors of parastomal hernia after ileal conduit diversion in Japanese population
|
Maruo, Kazutaka |
|
|
25 |
10 |
p. 1830-1834 |
artikel |
10 |
Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation
|
Teshima, Yasutomo |
|
|
25 |
10 |
p. 1870-1878 |
artikel |
11 |
Intracellular accumulation of PD-1 molecules in circulating T lymphocytes in advanced malignant melanoma: an implication for immune evasion mechanism
|
Takahashi, Ryo |
|
|
25 |
10 |
p. 1861-1869 |
artikel |
12 |
Long-term cognitive outcome in adult survivors of an early childhood posterior fossa brain tumour
|
Wagner, Adam P. |
|
|
25 |
10 |
p. 1763-1773 |
artikel |
13 |
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study)
|
Okano, Naohiro |
|
|
25 |
10 |
p. 1835-1843 |
artikel |
14 |
Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303)
|
Kobayashi, Daisuke |
|
|
25 |
10 |
p. 1793-1799 |
artikel |
15 |
Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial
|
Kobayashi, Minoru |
|
|
25 |
10 |
p. 1814-1821 |
artikel |
16 |
The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan
|
Kawakita, Daisuke |
|
|
25 |
10 |
p. 1774-1785 |
artikel |
17 |
Why is renal impairment associated with poorer cancer specific survival in breast cancer patients?: a comparison with patients with other comorbidities
|
Evans, Andy |
|
|
25 |
10 |
p. 1786-1792 |
artikel |